{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:20:39Z","timestamp":1795044039683,"version":"4.10.2"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Carr Fund"},{"name":"MAC AIDS Fund"},{"DOI":"10.13039\/100000919","name":"Open Society Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are an estimated 3.2 million women who inject drugs worldwide, constituting 20% of all people who inject drugs. The limited data that are available suggest that women who inject drugs are at greater risk of HIV and viral hepatitis acquisition than men who inject drugs. This increased vulnerability is a product of a range of environmental, social and individual factors affecting women, which also affect their ability to engage in health promoting services such as harm reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The researchers undertook a narrative literature review examining access to harm reduction services for women who use drugs in Europe and conducted semi-structured focus groups with women who use drugs and harm reduction and prison health workers in Barcelona, Spain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Women who use drugs face multiple barriers to accessing harm reduction services. These include stigma, both in society in general and from health and harm reduction workers in prisons and in the community; gender-based violence and a lack of services that are equipped to address the interaction between drug use and experiences of violence; criminalisation in the form of legal barriers to access, arrest and harassment from law enforcement, and incarceration; and a lack of services focused on the specific needs of women, notably sexual and reproductive health services and childcare. In Barcelona, participants reported experiencing all these barriers, and that their engagement with the Metzineres harm reduction centre had to some extent mitigated them. However, women continued to experience structural barriers to harm reduction service access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women and gender non-conforming people who use drugs face unique barriers to accessing harm reduction services. While services such as Metzineres can be life changing and life affirming for its members, it is incumbent on states to act to address the structural barriers to health faced by women who use drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-020-00429-5","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T10:03:12Z","timestamp":1603101792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-6796","authenticated-orcid":false,"given":"Sam","family":"Shirley-Beavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura","family":"Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Burke-Shyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Csak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"429_CR1","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5:e1192\u2013207.","journal-title":"Lancet Glob Health"},{"key":"429_CR2","volume-title":"Women who inject drugs: overlooked, yet visible","author":"International AIDS Society","year":"2019","unstructured":"International AIDS Society. Women who inject drugs: overlooked, yet visible. Geneva: International AIDS Society; 2019."},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2011.12.020","volume":"124","author":"DC Des Jarlais","year":"2012","unstructured":"Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124:95\u2013107.","journal-title":"Drug Alcohol Depend"},{"key":"429_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.socscimed.2019.01.022","volume":"222","author":"L Medina-Perucha","year":"2019","unstructured":"Medina-Perucha L, Scott J, Chapman S, Barnett J, Dack C, Family H. A qualitative study on intersectional stigma and sexual health among women on opioid substitution treatment in England: Implications for research, policy and practice. Soc Sci Med. 2019;222:315\u201322.","journal-title":"Soc Sci Med"},{"key":"429_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.drugpo.2004.06.009","volume":"15","author":"E Ettorre","year":"2004","unstructured":"Ettorre E. Revisioning women and drug use: gender sensitivity, embodiment and reducing harm. Int J Drug Policy. 2004;15:327\u201335.","journal-title":"Int J Drug Policy"},{"key":"429_CR6","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1097\/QAI.0000000000000623","volume":"69","author":"S Larney","year":"2015","unstructured":"Larney S, Mathers BM, Poteat T, Kamarulzaman A, Degenhardt L. Global epidemiology of HIV among women and girls who use or inject drugs: current knowledge and limitations of existing data. J Acquir Immune Defic Syndr. 2015;69:S100\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"429_CR7","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1097\/QAI.0000000000000637","volume":"69","author":"SA Springer","year":"2015","unstructured":"Springer SA, Larney S, Alam-Mehrjerdi Z, Altice FL, Metzger D, Shoptaw S. Drug treatment as HIV prevention among women and girls who inject drugs from a global perspective: progress, gaps, and future directions. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S155-161.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"429_CR8","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","volume":"69","author":"J Iversen","year":"2015","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S176-181.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR9","unstructured":"International Network of People who Use Drugs, Asian Network of People who Use Drugs. Words matter! language statement and reference guide. London: International Network of People Who Use Drugs; nd."},{"key":"429_CR10","volume-title":"Women who use drugs: issues, needs, responses, challenges and implications for policy and practice","author":"EMCDDA","year":"2017","unstructured":"EMCDDA. Women who use drugs: issues, needs, responses, challenges and implications for policy and practice. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2017."},{"key":"429_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/13698575.2013.868408","volume":"16","author":"C Stengel","year":"2014","unstructured":"Stengel C. The risk of being \u2018too honest\u2019: drug use, stigma and pregnancy. Health Risk Soc. 2014;16:36\u201350.","journal-title":"Health Risk Soc"},{"key":"429_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/hojo.12216","volume":"56","author":"C Giacomello","year":"2017","unstructured":"Giacomello C. Women and drug policies in Latin America: a critical review of the United Nations resolution \u2018mainstreaming a gender perspective in drug-related policies and programmes.\u2019 Howard J Crime Justice. 2017;56:288\u2013308.","journal-title":"Howard J Crime Justice"},{"issue":"Suppl 2","key":"429_CR13","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/QAI.0000000000000624","volume":"69","author":"SA Strathdee","year":"2015","unstructured":"Strathdee SA, West BS, Reed E, Moazen B, Moazan B, Azim T, et al. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S110-117.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(10)61026-4","volume":"376","author":"N El-Bassel","year":"2010","unstructured":"El-Bassel N, Terlikbaeva A, Pinkham S. HIV and women who use drugs: double neglect, double risk. Lancet. 2010;376:312\u20134.","journal-title":"Lancet"},{"key":"429_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/COH.0b013e3283536ab2","volume":"7","author":"N El-Bassel","year":"2012","unstructured":"El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS. 2012;7:326\u201331.","journal-title":"Curr Opin HIV AIDS"},{"key":"429_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0968-8080(08)31345-7","volume":"16","author":"S Pinkham","year":"2008","unstructured":"Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. Reprod Health Matters. 2008;16:168\u201381.","journal-title":"Reprod Health Matters"},{"key":"429_CR17","doi-asserted-by":"publisher","first-page":"269123","DOI":"10.1155\/2012\/269123","volume":"2012","author":"S Pinkham","year":"2012","unstructured":"Pinkham S, Stoicescu C, Myers B. Developing effective health interventions for women who inject drugs: key areas and recommendations for program development and policy. Adv Prev Med. 2012;2012:269123.","journal-title":"Adv Prev Med"},{"issue":"Suppl 1","key":"429_CR18","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.drugpo.2014.09.003","volume":"26","author":"T Azim","year":"2015","unstructured":"Azim T, Bontell I, Strathdee SA. Women, drugs and HIV. Int J Drug Policy. 2015;26(Suppl 1):S16-21.","journal-title":"Int J Drug Policy"},{"issue":"Suppl 2","key":"429_CR19","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1097\/QAI.0000000000000621","volume":"69","author":"K Malinowska-Sempruch","year":"2015","unstructured":"Malinowska-Sempruch K. What interventions are needed for women and girls who use drugs? A global perspective. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S96-97.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR20","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/QAI.0000000000000627","volume":"69","author":"WM Wechsberg","year":"2015","unstructured":"Wechsberg WM, Deren S, Myers B, Kirtadze I, Zule WA, Howard B, et al. Gender-specific HIV prevention interventions for women who use alcohol and other drugs: the evolution of the science and future directions. J Acquir Immune Defic Syndr. 2015;69:S128\u201339.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1081\/ADA-120018838","volume":"29","author":"OS Ashley","year":"2003","unstructured":"Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29:19\u201353.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"429_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","volume":"80","author":"M Terplan","year":"2015","unstructured":"Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review. Prev Med. 2015;80:23\u201331.","journal-title":"Prev Med"},{"key":"429_CR23","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/cid\/ciw416","volume":"63","author":"AJ Low","year":"2016","unstructured":"Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63:1094\u2013104.","journal-title":"Clin Infect Dis"},{"key":"429_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7517-6-32","volume":"6","author":"W Sword","year":"2009","unstructured":"Sword W, Jack S, Niccols A, Milligan K, Henderson J, Thabane L. Integrated programs for women with substance use issues and their children: a qualitative meta-synthesis of processes and outcomes. Harm Reduct J. 2009;6:32.","journal-title":"Harm Reduct J"},{"key":"429_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","volume":"13","author":"VA Earnshaw","year":"2009","unstructured":"Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13:1160.","journal-title":"AIDS Behav"},{"key":"429_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131:23\u201335.","journal-title":"Drug Alcohol Depend"},{"key":"429_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11904-013-0196-2","volume":"11","author":"M Malta","year":"2014","unstructured":"Malta M, Ralil da Costa M, Bastos FI. The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs? Curr HIV\/AIDS Rep. 2014;11:52\u201362.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"429_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cpr.2007.05.003","volume":"28","author":"TM Moore","year":"2008","unstructured":"Moore TM, Stuart GL, Meehan JC, Rhatigan DL, Hellmuth JC, Keen SM. Drug abuse and aggression between intimate partners: a meta-analytic review. Clin Psychol Rev. 2008;28:247\u201374.","journal-title":"Clin Psychol Rev"},{"key":"429_CR29","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1097\/QAI.0000000000000626","volume":"69","author":"L Gilbert","year":"2015","unstructured":"Gilbert L, Raj A, Hien D, Stockman J, Terlikbayeva A, Wyatt G. Targeting the SAVA (substance abuse, violence and AIDS) syndemic among women and girls: a global review of epidemiology and integrated interventions. J Acquir Immune Defic Syndr. 2015;69:S118\u201327.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR30","doi-asserted-by":"publisher","first-page":"18845","DOI":"10.7448\/IAS.17.1.18845","volume":"17","author":"Y Li","year":"2014","unstructured":"Li Y, Marshall CM, Rees HC, Nunez A, Ezeanolue EE, Ehiri JE. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. J Int AIDS Soc. 2014;17:18845.","journal-title":"J Int AIDS Soc"},{"key":"429_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/10826084.2011.523296","volume":"46","author":"N El-Bassel","year":"2011","unstructured":"El-Bassel N, Gilbert L, Witte S, Wu E, Chang M. Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics\u2013challenges and implications for prevention and treatment. Subst Use Misuse. 2011;46:295\u2013306.","journal-title":"Subst Use Misuse"},{"key":"429_CR32","volume-title":"Global state of harm reduction 2020","author":"Harm Reduction International","year":"2020","unstructured":"Harm Reduction International. Global state of harm reduction 2020. London: Harm Reduction International; 2020."},{"key":"429_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12916-019-1271-3","volume":"17","author":"AL Stangl","year":"2019","unstructured":"Stangl AL, Earnshaw VA, Logie CH, van Brakel W, Simbayi LC, Barr\u00e9 I, et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17:31.","journal-title":"BMC Med"},{"key":"429_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/01973533.2012.746612","volume":"35","author":"SR Chaudoir","year":"2013","unstructured":"Chaudoir SR, Earnshaw VA, Andel S. \u201cDiscredited\u201d versus \u201cdiscreditable\u201d: understanding how shared and unique stigma mechanisms affect psychological and physical health disparities. Basic Appl Soc Psychol. 2013;35:75\u201387.","journal-title":"Basic Appl Soc Psychol"},{"key":"429_CR35","unstructured":"Barlee D. Stigma and the health of vulnerable women. MSFHR: Women\u2019s Health Research Network. https:\/\/www.academia.edu\/5994388\/Stigma_and_the_Health_of_Vulnerable_Women. Accessed 28 Jul 2020"},{"key":"429_CR36","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/1475-6773.13222","volume":"54","author":"DR Williams","year":"2019","unstructured":"Williams DR, Lawrence JA, Davis BA, Vu C. Understanding how discrimination can affect health. Health Serv Res. 2019;54:1374\u201388.","journal-title":"Health Serv Res"},{"key":"429_CR37","volume-title":"Stigma: notes on the management of spoiled identity","author":"E Goffman","year":"2009","unstructured":"Goffman E. Stigma: notes on the management of spoiled identity. London: Simon and Schuster; 2009."},{"key":"429_CR38","volume-title":"Protocol for identification of discrimination against people living with HIV","author":"UNAIDS","year":"2000","unstructured":"UNAIDS. Protocol for identification of discrimination against people living with HIV. Geneva: Joint United Nations Programme on HIV\/AIDS; 2000."},{"key":"429_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12916-019-1256-2","volume":"17","author":"L Nyblade","year":"2019","unstructured":"Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Lean RM, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17:25.","journal-title":"BMC Med"},{"key":"429_CR40","volume-title":"Global fund breaking down barriers initiative: summary of key findings of the baseline assessments in 20 countries","author":"The Global Fund","year":"2020","unstructured":"The Global Fund. Global fund breaking down barriers initiative: summary of key findings of the baseline assessments in 20 countries. Geneva: The Global Fund; 2020."},{"key":"429_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drugpo.2016.01.012","volume":"30","author":"S Zamudio-Haas","year":"2016","unstructured":"Zamudio-Haas S, Mahenge B, Saleem H, Mbwambo J, Lambdin BH. Generating trust: programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania. Int J Drug Policy. 2016;30:43\u201351.","journal-title":"Int J Drug Policy"},{"key":"429_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2015.12.019","volume":"30","author":"B Myers","year":"2016","unstructured":"Myers B, Carney T, Wechsberg WM. \u201cNot on the agenda\u201d: a qualitative study of influences on health services use among poor young women who use drugs in Cape Town, South Africa. Int J Drug Policy. 2016;30:52\u20138.","journal-title":"Int J Drug Policy"},{"key":"429_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.drugpo.2013.05.004","volume":"24","author":"D Otiashvili","year":"2013","unstructured":"Otiashvili D, Kirtadze I, O\u2019Grady KE, Zule W, Krupitsky E, Wechsberg WM, et al. Access to treatment for substance-using women in the Republic of Georgia: socio-cultural and structural barriers. Int J Drug Policy. 2013;24:566\u201372.","journal-title":"Int J Drug Policy"},{"key":"429_CR44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.drugpo.2015.07.011","volume":"26","author":"C Spooner","year":"2015","unstructured":"Spooner C, Saktiawati AMI, Lazuardi E, Worth H, Subronto YW, Padmawati RS. Impacts of stigma on HIV risk for women who inject drugs in Java: a qualitative study. Int J Drug Policy. 2015;26:1244\u201350.","journal-title":"Int J Drug Policy"},{"key":"429_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0740-5472(96)00108-0","volume":"14","author":"J Copeland","year":"1997","unstructured":"Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. J Subst Abuse Treat. 1997;14:183\u201390.","journal-title":"J Subst Abuse Treat"},{"key":"429_CR46","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/09540121.2017.1394965","volume":"30","author":"S Ayon","year":"2018","unstructured":"Ayon S, Ndimbii J, Jeneby F, Abdulrahman T, Mlewa O, Wang B, et al. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers. AIDS Care. 2018;30:480\u20137.","journal-title":"AIDS Care"},{"key":"429_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12954-015-0067-9","volume":"12","author":"OT Khuat","year":"2015","unstructured":"Khuat OT, Morrow M, Nguyen TN, Armstrong G. Social context, diversity and risk among women who inject drugs in Vietnam: descriptive findings from a cross-sectional survey. Harm Reduct J. 2015;12:35.","journal-title":"Harm Reduct J"},{"key":"429_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(14)61042-4","volume":"385","author":"M Rusakova","year":"2015","unstructured":"Rusakova M, Rakhmetova A, Strathdee SA. Why are sex workers who use substances at risk for HIV? Lancet. 2015;385:211\u20132.","journal-title":"Lancet"},{"key":"429_CR49","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/QAI.0b013e3182968d39","volume":"63","author":"KN Deering","year":"2013","unstructured":"Deering KN, Lyons T, Feng CX, Nosyk B, Strathdee SA, Montaner JS, et al. Client demands for unsafe sex: the socio-economic risk environment for HIV among street and off-street sex workers. J Acquir Immune Defic Syndr. 2013;63:522\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR50","volume-title":"UNAIDS guidance note on HIV and sex work","author":"UNAIDS","year":"2009","unstructured":"UNAIDS. UNAIDS guidance note on HIV and sex work. Geneva: Joint United Nations Programme on HIV\/AIDS; 2009."},{"key":"429_CR51","unstructured":"World Health Organization, Department of Reproductive Health and Research, London School of Hygiene and Tropical Medicine, South African Medical Research Council. Global and regional estimates of violence against women. Geneva: World Health Organization; 2013."},{"key":"429_CR52","volume-title":"Women and HIV: a spotlight on adolescent girls and young women","author":"UNAIDS","year":"2019","unstructured":"UNAIDS. Women and HIV: a spotlight on adolescent girls and young women. Geneva: Joint United Nations Programme on HIV\/AIDS; 2019."},{"key":"429_CR53","unstructured":"Gender-Based Violence (Violence Against Women and Girls). World Bank. 2019. https:\/\/www.worldbank.org\/en\/topic\/socialdevelopment\/brief\/violence-against-women-and-girls. Accessed on 28 July 2020"},{"key":"429_CR54","first-page":"0230886","volume":"15","author":"J Valencia","year":"2020","unstructured":"Valencia J, Alvaro-Meca A, Troya J, Guti\u00e9rrez J, Ram\u00f3n C, Rodr\u00edguez A, et al. Gender-based vulnerability in women who inject drugs in a harm reduction setting. PLoS ONE. 2020;15:0230886.","journal-title":"PLoS ONE"},{"key":"429_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12905-017-0372-4","volume":"17","author":"R Mason","year":"2017","unstructured":"Mason R, Wolf M, O\u2019Rinn S, Ene G. Making connections across silos: intimate partner violence, mental health, and substance use. BMC Women\u2019s Health. 2017;17:29.","journal-title":"BMC Women\u2019s Health"},{"key":"429_CR56","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0277-9536(94)90205-4","volume":"39","author":"M Singer","year":"1994","unstructured":"Singer M. AIDS and the health crisis of the U.S. urban poor; the perspective of critical medical anthropology. Soc Sci Med. 1994;39:931\u201348.","journal-title":"Soc Sci Med"},{"key":"429_CR57","volume-title":"Improving the management of violence experienced by women who use psychoactive substances","author":"T Benoit","year":"2016","unstructured":"Benoit T, Jauffret-Roustide M. Improving the management of violence experienced by women who use psychoactive substances. Strasbourg: Council of Europe; 2016."},{"key":"429_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/02791072.2007.10400611","volume":"39","author":"H Kunins","year":"2007","unstructured":"Kunins H, Gilbert L, Whyte-Etere A, Meissner P, Zachary M. Substance abuse treatment staff perceptions of intimate partner victimization among female clients. J Psychoact Drugs. 2007;39:251\u20137.","journal-title":"J Psychoact Drugs"},{"key":"429_CR59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1037\/vio0000074","volume":"8","author":"B Cafferky","year":"2018","unstructured":"Cafferky B, Mendez M, Anderson J, Stith S. Substance use and intimate partner violence. Psychol Violence. 2018;8:110\u201331.","journal-title":"Psychol Violence"},{"key":"429_CR60","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(02)08336-8","volume":"359","author":"JC Campbell","year":"2002","unstructured":"Campbell JC. Health consequences of intimate partner violence. Lancet (Lond Engl). 2002;359:1331\u20136.","journal-title":"Lancet (Lond Engl)"},{"key":"429_CR61","first-page":"517","volume":"16","author":"L Gilbert","year":"2001","unstructured":"Gilbert L, El-Bassel N, Rajah V, Foleno A, Frye V. Linking drug-related activities with experiences of partner violence: a focus group study of women in methadone treatment. Violence Vict. 2001;16:517\u201336.","journal-title":"Violence Vict"},{"key":"429_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.socscimed.2004.11.035","volume":"61","author":"N El-Bassel","year":"2005","unstructured":"El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med. 2005;61:171\u201383.","journal-title":"Soc Sci Med"},{"key":"429_CR63","first-page":"154","volume":"12","author":"N El-Bassel","year":"2000","unstructured":"El-Bassel N, Gilbert L, Rajah V, Foleno A, Frye V. Fear and violence: raising the HIV stakes. AIDS Educ Prev. 2000;12:154\u201370.","journal-title":"AIDS Educ Prev"},{"key":"429_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugpo.2013.06.005","volume":"25","author":"L Beletsky","year":"2014","unstructured":"Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York city: a community-level perspective. Int J Drug Policy. 2014;25:105\u201311.","journal-title":"Int J Drug Policy"},{"key":"429_CR65","volume-title":"Expecting better: improving health and rights for pregnant women who use drugs","author":"B Medley","year":"2018","unstructured":"Medley B, Thumath M. Expecting better: improving health and rights for pregnant women who use drugs. New York: Open Society Foundations; 2018."},{"key":"429_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12954-016-0109-y","volume":"13","author":"N Kappel","year":"2016","unstructured":"Kappel N, Toth E, Tegner J, Lauridsen S. A qualitative study of how Danish drug consumption rooms influence health and well-being among people who use drugs. Harm Reduct J. 2016;13:20.","journal-title":"Harm Reduct J"},{"key":"429_CR67","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/002204260203200315","volume":"32","author":"J Flavin","year":"2002","unstructured":"Flavin J. A glass half full? Harm reduction among pregnant women who use cocaine. J Drug Issues. 2002;32:973\u201398.","journal-title":"J Drug Issues"},{"key":"429_CR68","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1097\/QAI.0000000000000628","volume":"69","author":"N El-Bassel","year":"2015","unstructured":"El-Bassel N, Strathdee SA. Women who use or inject drugs: an action agenda for women-specific, multilevel and combination HIV prevention and research. J Acquir Immune Defic Syndr. 2015;69:S182\u201390.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR69","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jama.2010.1090","volume":"304","author":"K Shannon","year":"2010","unstructured":"Shannon K, Csete J. Violence, condom negotiation, and HIV\/STI risk among sex workers. JAMA. 2010;304:573\u20134.","journal-title":"JAMA"},{"key":"429_CR70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1477-7517-6-28","volume":"6","author":"SL Davis","year":"2009","unstructured":"Davis SL, Triwahyuono A, Alexander R. Survey of abuses against injecting drug users in Indonesia. Harm Reduct J. 2009;6:28.","journal-title":"Harm Reduct J"},{"key":"429_CR71","unstructured":"Walmsley R. World female imprisonment list (fourth edition) [Internet]. Institute for Criminal Policy Research; 2017. https:\/\/www.prisonstudies.org\/sites\/default\/files\/resources\/downloads\/world_female_prison_4th_edn_v4_web.pdf"},{"key":"429_CR72","unstructured":"UNODC. World drug report 2018. Vienna; 2018."},{"key":"429_CR73","volume-title":"Global state of harm reduction 2018","author":"K Stone","year":"2018","unstructured":"Stone K, Shirley-Beavan S. Global state of harm reduction 2018. London: Harm Reduction International; 2018."},{"key":"429_CR74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1078345819837909","volume":"25","author":"G Sander","year":"2019","unstructured":"Sander G, Shirley-Beavan S, Stone K. The global state of harm reduction in prisons. J Correct Health Care. 2019;25:105\u201320.","journal-title":"J Correct Health Care"},{"key":"429_CR75","volume-title":"International review of women\u2019s prisons","author":"H Fair","year":"2009","unstructured":"Fair H. International review of women\u2019s prisons. London: International Centre for Prison Studies, Kings College; 2009."},{"key":"429_CR76","volume-title":"Women, harm reduction, and HIV: key findings from Azerbaijan, Georgia, Kyrgyzstan, Russia and Ukraine","author":"K Burns","year":"2009","unstructured":"Burns K. Women, harm reduction, and HIV: key findings from Azerbaijan, Georgia, Kyrgyzstan, Russia and Ukraine. New York: Open Society Foundations; 2009."},{"key":"429_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/08974454.2017.1307160","volume":"28","author":"E van der Meulen","year":"2018","unstructured":"van der Meulen E, Shalit AD, Chu SKH. A legacy of harm: punitive drug policies and women\u2019s carceral experiences in Canada. Women Crim Justice. 2018;28:81\u201399.","journal-title":"Women Crim Justice"},{"key":"429_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/16066359609010754","volume":"4","author":"K Dolan","year":"1996","unstructured":"Dolan K, Wodak A, Hall W, Gaughwin M, Rae F. HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales. Addict Res. 1996;4:151\u201360.","journal-title":"Addict Res"},{"key":"429_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1300\/J013v40n04_04","volume":"40","author":"L Rehman","year":"2004","unstructured":"Rehman L, Gahagan J, DiCenso AM, Dias G. Harm reduction and women in the Canadian national prison system: policy or practice? Women Health. 2004;40:57\u201373.","journal-title":"Women Health"},{"key":"429_CR80","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1111\/j.1440-1746.2009.05978.x","volume":"24","author":"K Dolan","year":"2009","unstructured":"Dolan K, Larney S, Jacka B, Rawlinson W. Presence of hepatitis C virus in syringes confiscated in prisons in Australia. J Gastroenterol Hepatol. 2009;24:1655\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"429_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0955-3959(99)00007-9","volume":"10","author":"S Boyd","year":"1999","unstructured":"Boyd S, Faith K. Women, illegal drugs and prison: views from Canada. Int J Drug Policy. 1999;10:195\u2013207.","journal-title":"Int J Drug Policy"},{"key":"429_CR82","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1046\/j.1360-0443.2002.00229.x","volume":"97","author":"A Boys","year":"2002","unstructured":"Boys A, Farrell M, Bebbington P, Brugha T, Coid J, Jenkins R, et al. Drug use and initiation in prison: results from a national prison survey in England and Wales. Addiction. 2002;97:1551\u201360.","journal-title":"Addiction"},{"key":"429_CR83","volume-title":"Office of the correctional investigator annual report 2018\u20132019","author":"I Zinger","year":"2019","unstructured":"Zinger I. Office of the correctional investigator annual report 2018\u20132019. Ottawa: Office of the Correctional Investigator; 2019."},{"key":"429_CR84","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11901-019-00468-y","volume":"18","author":"T Kushner","year":"2019","unstructured":"Kushner T, Chappell CA, Kim AY. Testing for hepatitis C in pregnancy: the time has come for routine rather than risk-based. Curr Hepatol Rep. 2019;18:206\u201315.","journal-title":"Curr Hepatol Rep"},{"issue":"3","key":"429_CR85","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0277-9536(02)00403-3","volume":"57","author":"P Braitstein","year":"2003","unstructured":"Braitstein P, Li K, Tyndall M, Spittal P, O\u2019Shaughnessy MV, Schilder A. Sexual violence among a cohort of injection drug users. Soc Sci Med. 2003;57(3):561\u20139.","journal-title":"Soc Sci Med"},{"issue":"69 Suppl 2","key":"429_CR86","first-page":"S146","volume":"2015","author":"JD Auerbach","year":"1999","unstructured":"Auerbach JD, Smith LR. Theoretical foundations of research focused on HIV prevention among substance-involved women: a review of observational and intervention studies. J Acquir Immune Defic Syndr. 1999;2015(69 Suppl 2):S146\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"429_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10461-014-0772-5","volume":"19","author":"MD Ulibarri","year":"2015","unstructured":"Ulibarri MD, Roesch S, Rangel MG, Staines H, Amaro H, Strathdee SA. \u201cAmar te Duele\u201d (\u201clove hurts\u201d): sexual relationship power, intimate partner violence, depression symptoms and HIV risk among female sex workers who use drugs and their non-commercial, steady partners in Mexico. AIDS Behav. 2015;19:9\u201318.","journal-title":"AIDS Behav"},{"key":"429_CR88","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/109019810002700502","volume":"27","author":"GM Wingood","year":"2000","unstructured":"Wingood GM, DiClemente RJ. Application of the theory of gender and power to examine HIV-related exposures, risk factors, and effective interventions for women. Health Educ Behav. 2000;27:539\u201365.","journal-title":"Health Educ Behav"},{"key":"429_CR89","unstructured":"Federal Office of Statistics. Nombre de D\u00e9c\u00e8s Li\u00e9s \u00e0 la Drogue, Par \u00c2ge (1995\u20132016) (downloadable spreadsheet). Sucht Monitoring; 2017. https:\/\/www.suchtmonitoring.ch\/fr\/3\/7.html?opioides-mortalite.\nAccessed 16 May 2020."},{"key":"429_CR90","unstructured":"Federal Office of Statistics. Nombre de D\u00e9c\u00e8s Li\u00e9s \u00e0 la Drogue Chez les Femmes, Par \u00c2ge (1995\u20132016) (downloadable spreadsheet). Sucht monitoring; 2017. https:\/\/www.suchtmonitoring.ch\/fr\/3\/7.html?opioides-mortalite. Accessed 16 May 2020."},{"key":"429_CR91","unstructured":"Federal Office of Statistics. Nombre de D\u00e9c\u00e8s Li\u00e9s \u00e0 la Drogue Chez les Hommes, Par \u00c2ge (1995\u20132016) (downloadable spreadsheet). Sucht monitoring; 2017. https:\/\/www.suchtmonitoring.ch\/fr\/3\/7.html?opioides-mortalite. Accessed 16 May 2020."},{"key":"429_CR92","volume-title":"Malta drug report 2018","author":"EMCDDA","year":"2018","unstructured":"EMCDDA. Malta drug report 2018. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2018."},{"key":"429_CR93","unstructured":"EMCDDA. Germany, country drug report 2019. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2019. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/11334\/germany-cdr-2019_0.pdf. Accessed 16 May 2020."},{"key":"429_CR94","unstructured":"Stone K, Shirley-Beavan S. Global state of harm reduction 2018. London: Harm Reduction International; 2018. https:\/\/www.hri.global\/global-state-harm-reduction-2018. Accessed 5 May 2020."},{"key":"429_CR95","volume-title":"International Narcotics Control Board Report 2016","author":"INCB","year":"2016","unstructured":"INCB. International Narcotics Control Board Report 2016. Vienna: International Narcotics Control Board; 2016."},{"key":"429_CR96","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/cid\/cix768","volume":"66","author":"A Esmaeili","year":"2018","unstructured":"Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, et al. The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multicohort InC3 collaborative. Clin Infect Dis. 2018;66:20\u20138.","journal-title":"Clin Infect Dis"},{"key":"429_CR97","unstructured":"Addaction. Addaction launches UK\u2019s first pharmacy-based needle exchange dispenser|Addaction; 2018. https:\/\/www.addaction.org.uk\/news\/addaction-launches-uk%E2%80%99s-first-pharmacy-based-needle-exchange-dispenser. Accessed 1 Aug 2018."},{"key":"429_CR98","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/joim.12740","volume":"283","author":"S Olafsson","year":"2018","unstructured":"Olafsson S, Tyrfingsson T, Runarsdottir V, Bergmann OM, Hansdottir I, Bj\u00f6rnsson ES, et al. Treatment as prevention for hepatitis C (TraP Hep C)\u2014a nationwide elimination programme in Iceland using direct-acting antiviral agents. J Intern Med. 2018;283:500\u20137.","journal-title":"J Intern Med"},{"key":"429_CR99","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.drugpo.2012.01.003","volume":"23","author":"A Olsen","year":"2012","unstructured":"Olsen A, Banwell C, Dance P, Maher L. Positive health beliefs and behaviours in the midst of difficult lives: women who inject drugs. Int J Drug Policy. 2012;23:312\u20138.","journal-title":"Int J Drug Policy"},{"key":"429_CR100","unstructured":"Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use. Women who inject drugs: a review of their risks, experiences and needs. Sydney: National Drug and Alcohol Research Centre, UNSW Australia; 2010."},{"key":"429_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/dar.12165","volume":"34","author":"S Taplin","year":"2015","unstructured":"Taplin S, Mattick RP. The nature and extent of child protection involvement among heroin-using mothers in treatment: high rates of reports, removals at birth and children in care. Drug Alcohol Rev. 2015;34:31\u20137.","journal-title":"Drug Alcohol Rev"},{"key":"429_CR102","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/02791072.2008.10400661","volume":"40","author":"CE Grella","year":"2008","unstructured":"Grella CE. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoact Drugs. 2008;40:327\u201343.","journal-title":"J Psychoact Drugs"},{"key":"429_CR103","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.addbeh.2011.09.009","volume":"37","author":"L Sordo","year":"2012","unstructured":"Sordo L, Chahua M, Bravo MJ, Barrio G, Brugal MT, Domingo-Salvany A, et al. Depression among regular heroin users: the influence of gender. Addict Behav. 2012;37:148\u201352.","journal-title":"Addict Behav"},{"key":"429_CR104","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0740-5472(99)00091-4","volume":"19","author":"GA Rowan-Czal","year":"2000","unstructured":"Rowan-Czal GA, Chatham LR, Joe GW, Simpson DD. Services provided during methadone treatment. A gender comparison. J Subst Abuse Treat. 2000;19:7\u201314.","journal-title":"J Subst Abuse Treat"},{"key":"429_CR105","first-page":"32","volume":"26","author":"J Du","year":"2013","unstructured":"Du J, Huang D, Zhao M, Hser YI. Drug-abusing offenders with co-morbid mental disorders: gender differences in problem severity, treatment participation, and recidivism. Biomed Environ Sci. 2013;26:32\u20139.","journal-title":"Biomed Environ Sci"},{"key":"429_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17159\/sajs.2018\/4451","volume":"114","author":"S Dada","year":"2018","unstructured":"Dada S, Burnhams NH, Laubscher R, Parry C, Myers B. Alcohol and other drug use among women seeking substance abuse treatment in the Western Cape, South Africa. S Afr J Sci. 2018;114:1\u20137.","journal-title":"S Afr J Sci"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00429-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-020-00429-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00429-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T20:11:32Z","timestamp":1634587892000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-020-00429-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00429-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-54214\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethical approval from the Ethics Committee of the Institut d\u2019Investicio Sanitaria Pere Virgili in Barcelona, Spain. All of the participants signed a consent form approved by the Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}